Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1927779> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- Q1927779 subject Q6809264.
- Q1927779 subject Q7149601.
- Q1927779 subject Q8522218.
- Q1927779 subject Q9157901.
- Q1927779 abstract "Vaginal rings (also known as intravaginal rings, or V-Rings) are polymeric drug delivery devices designed to provide controlled release of drugs for intravaginal administration over extended periods of time. The ring is inserted into the vagina and provides contraception protection. Leaving the ring in for three weeks slowly releases hormones into the body, mainly vaginally administered estrogens and/or progestogens (a group of hormones including progesterone). These hormones stop ovulation and thicken the cervical mucus, creating a barrier preventing sperm from fertilizing an egg. Worn continuously for three weeks followed by a week off, each vaginal ring provides one month of birth control. Several vaginal ring products are currently available, including: Estring - a low-dose estradiol-releasing ring, manufactured from silicone elastomer, for the treatment of vaginal atrophy (atrophic vaginitis). Femring - a low-dose estradiol-acetate releasing ring, manufactured from silicone elastomer, for the relief of hot flashes and vaginal atrophy associated with menopause. NuvaRing - a low-dose contraceptive vaginal ring, manufactured from poly(ethylene-co-vinyl acetate), and releasing etonogestrel (a progestin) ethinyl estradiol (an estrogen). Progering, containing progesterone as a sole ingredient, is available only in Chile and Peru.A number of vaginal ring products are also in development.".
- Q1927779 thumbnail NuvaRing_in_hand.jpg?width=300.
- Q1927779 wikiPageExternalLink www.estring.com.
- Q1927779 wikiPageExternalLink www.femring.com.
- Q1927779 wikiPageExternalLink www.nuvaring.com.
- Q1927779 wikiPageWikiLink Q11320751.
- Q1927779 wikiPageWikiLink Q12171.
- Q1927779 wikiPageWikiLink Q122224.
- Q1927779 wikiPageWikiLink Q1392806.
- Q1927779 wikiPageWikiLink Q17014824.
- Q1927779 wikiPageWikiLink Q177708.
- Q1927779 wikiPageWikiLink Q1858291.
- Q1927779 wikiPageWikiLink Q194520.
- Q1927779 wikiPageWikiLink Q26963.
- Q1927779 wikiPageWikiLink Q277954.
- Q1927779 wikiPageWikiLink Q3733839.
- Q1927779 wikiPageWikiLink Q395.
- Q1927779 wikiPageWikiLink Q4007235.
- Q1927779 wikiPageWikiLink Q415563.
- Q1927779 wikiPageWikiLink Q422416.
- Q1927779 wikiPageWikiLink Q45071.
- Q1927779 wikiPageWikiLink Q5880.
- Q1927779 wikiPageWikiLink Q6058566.
- Q1927779 wikiPageWikiLink Q666412.
- Q1927779 wikiPageWikiLink Q6809264.
- Q1927779 wikiPageWikiLink Q7070620.
- Q1927779 wikiPageWikiLink Q7149601.
- Q1927779 wikiPageWikiLink Q8522218.
- Q1927779 wikiPageWikiLink Q9157901.
- Q1927779 comment "Vaginal rings (also known as intravaginal rings, or V-Rings) are polymeric drug delivery devices designed to provide controlled release of drugs for intravaginal administration over extended periods of time. The ring is inserted into the vagina and provides contraception protection. Leaving the ring in for three weeks slowly releases hormones into the body, mainly vaginally administered estrogens and/or progestogens (a group of hormones including progesterone).".
- Q1927779 label "Vaginal ring".
- Q1927779 depiction NuvaRing_in_hand.jpg.